Meningococcal B Vaccine Fails to Protect Against Gonorrhea

A new randomized controlled trial (RCT) published in the New England Journal of Medicine (NEJM) has found that the Meningitis B vaccine does not prevent gonorrhea infections despite a year-long mass vaccination campaign targeting at-risk men in the United Kingdom. After gonorrhea cases exceeded the highest levels ever recorded, the U.K.’s National Health Service (NHS) […]
Oral Vaccine Being Developed for Invasive Bacterial Diarrhea

Researchers are taking steps toward developing an live attenuated oral vaccine aimed at preventing invasive bacterial diarrhea caused by the Shigella bacteria.1 The Shigella bacteria can cause shigellosis—an intestinal infection characterized by diarrhea, fever and stomach cramps. It is one of four highly contagious bacteria that infects tens of millions of people around the world.2 […]
Oncologist Calls for Banning COVID-19 Shots, as Congress Debates Whether They Cause or Accelerate Cancer

British oncologist and immunologist Angus Dalgleish, MD called for a ban of COVID-19 shots in testimony during a U.S. Senate hearing on COVID shot safety on June 3, 2026, citing an observed “marked increase in unexpected cancers among boosted patients.” Heard by the Senate Permanent Subcommittee on Investigations, the subcommittee convened to discuss whether mRNA […]
CDC Just Awarded Pfizer $1.2 Billion for COVID-19 Shots

U.S. federal procurement records published in June 2026 show that the U.S. Centers for Disease Control and Prevention (CDC) awarded Pfizer more than $1.24 billion in contracts for adult and pediatric mRNA COVID-19 shots for fiscal years 2026 and 2027. The contracts, which were published on SAM.gov and contained more money allocated for pediatric COVID […]
Experimental Vaccine to Prevent Fentanyl Overdose Enters Human Trials

An experimental “anti-fentanyl” vaccine developed by ARMR Sciences, Inc. of New York and the University of Houston has entered Phase 1/2 human trials, according to a June 17 press release issued by the company. The vaccine candidate has spent years in development and vaccine developers say it represents a potential intervention in America’s ongoing overdose […]
Mussel Protein Used to Develop New Vaccine Technology

Scientists in South Korea have developed a new adhesive adjuvant protein-based nanoparticle vaccine technology that they believe may provide longer-lasting immunity with a single injection. According to the researchers in a study published in the journal Biomaterials in 2026, the new approach used bioengineering, gene synthesis and cloning to create a new vaccine technology using […]
